Metabolism-clinical And Experimental

SCI SCIE

国际简称：METABOLISM 参考译名：代谢-临床和实验

主要研究方向：医学-内分泌学与代谢非预警期刊审稿周期：约1月

《代谢-临床和实验》(Metabolism-clinical And Experimental)是一本由W.B. Saunders Ltd出版的以医学-内分泌学与代谢为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
156 年发文量
16.7 IF影响因子
未开放 是否OA
122 H-index
1952 创刊年份
Monthly 出版周期
English 出版语言

Metabolism promotes excellence in research by publishing high-quality original research papers, fast-tracking cutting-edge papers, research brief reports, mini-reviews, and other special articles related to all aspects of human metabolism. Work considered for publication in Metabolism includes studies in humans, animal and cellular models. Work with strong translational potential is prioritized.

[ 查看全部 ]

投稿咨询加急咨询

Metabolism-clinical And Experimental期刊信息

ISSN：0026-0495
出版语言：English
是否OA：未开放
E-ISSN：1532-8600
出版地区：UNITED STATES
是否预警：否
出版商：W.B. Saunders Ltd
出版周期：Monthly
创刊时间：1952
开源占比：0.1871
Gold OA文章占比：21.26%
OA被引用占比：0.0578...
出版国人文章占比：0.11
出版撤稿占比：0
研究类文章占比：83.97%

Metabolism-clinical And Experimental CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

21.3

4.328

2.855

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Endocrinology	Q1	6 / 132	95%
大类：Biochemistry, Genetics and Molecular Biology 小类：Endocrinology, Diabetes and Metabolism	Q1	11 / 250	95%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Metabolism-clinical And Experimental中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	1区

Metabolism-clinical And Experimental JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	9 / 198	95.7
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	9 / 198	95.71

Metabolism-clinical And Experimental历年数据统计

影响因子

中科院分区

Metabolism-clinical And Experimental中国学者发文选摘

1、6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3: A potential target in the development of diabetes and its complication
Author: Jiang, Minmin; An, Xiaofei

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 180, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156621
2、Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integratio
Author: Song, Wei; Nie, Xiaoqian; Zhu, Zhenghong; Wang, Qiong; Zhao, Bingjia; An, Yang; Maimaiti, Adila; Liang, Xiaochun; Zhang, Qian

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 180, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156601
3、SREBP2 links ACSS2-dependent acetyl-CoA biosynthesis to metaboloepigenetic activation of hepatic stellate cells and liver fibrosi
Author: Wang, Yu; Kang, Aoqi; Wang, Shunjie; Yang, Zhen; Liu, Hong; Yue, Linbo; Li, Hao; Wu, Caiyi; Ren, Wenjing; Miao, Xiulian; Li, Zilong; Xu, Yong; Fan, Zhiwen

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156597
4、Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0-
Author: Weng, Bingtao; Wei, Jiahe; Chen, Han; Zhao, Yuyan; Wang, Ningjian; Feng, Hongliang; Ai, Sizhi; Tan, Xiao

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156600
5、Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: Evidence from multi-cohorts in China, the UK, and the U
Author: Xue, Erxu; Zhao, Jianhui; Chen, Bowen; Ye, Jingyu; Wu, Jingjie; Shao, Jing; Li, Xue; Ye, Zhihong

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156596
6、From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosi
Author: Hu, Xun; Long, Long

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156550
7、Targeting G(3γ subunits in hypothalamic AgRP neurons to treat obesit
Author: Xuan, Ye; Xiong, Xiaoyue; Wang, Xinyu; Wang, Yunqi; Shen, Yun; Zhang, Hong; Zhang, Rong; Chen, Liwei; Zhang, Peng; Zhang, Yi; Hu, Cheng

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156569
8、Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcome
Author: Liu, Lin; Cai, Anping; Wu, Kevin Chun Hei; Xu, Aimin; Lip, Gregory Y. H.; Cheng, Yunjiu; Cheung, Bernard M. Y.; Yiu, Kai-Hang

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156573